Show simple item record

dc.creatorZhulkevich, I. V.
dc.creatorYavorska, Yu. V.
dc.date2015-05-09
dc.date.accessioned2019-09-07T09:50:44Z
dc.date.available2019-09-07T09:50:44Z
dc.identifierhttps://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/5576
dc.identifier10.11603/2415-8798.2015.2.5576
dc.identifier.urihttps://repository.tdmu.edu.ua/handle/123456789/12042
dc.descriptionBone density alterations are often reported in patients with solid tumors and hematologic malignancies except cases of Hodgkin lymphoma, when this problem remains understudied. The aim of this study was to investigate the significance of patients’ age and ABVD standard chemotherapy regimen as the determinants of vertebral trabecular bone tissue status changes. The study included 40 HL patients of different age groups (median age 35.38 ± 2.22). Densitometric and structural parameters were obtained from pre-treatment and after chemo CT scans. Analysis of these parameters after chemotherapy compared to the initial values revealed significant decrease of bone density (maximum up to 24.9 %) in all age groups, as well as in patients who were treated with ABVD regimen. Structural parameters values (BV/TV, SMI, BS, FD, textural parameters) had also suggested trabecular transformation dependent on patients’ age and chemotherapy treatment. Age and ABVD standard chemotherapy may be considered as predisposing risk factors for trabecular bone structural alteration and there is a need for timely diagnosis and prevention.uk-UA
dc.formatapplication/pdf
dc.languageukr
dc.publisherТернопільський державний медичний університет ім. І.Я. Горбачевськогоuk-UA
dc.relationhttps://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/5576/5102
dc.rightsАвторське право (c) 2016 Вісник наукових дослідженьuk-UA
dc.sourceBulletin of Scientific Research; No 2 (2015)en-US
dc.sourceВестник научных исследований; № 2 (2015)ru-RU
dc.sourceВісник наукових досліджень; № 2 (2015)uk-UA
dc.source2415-8798
dc.source1681-276X
dc.source10.11603/2415-8798.2015.2
dc.titleAGE AS A DETERMINANT OF VERTEBRAL TRABECULAR BONE STATUS IN HODGKIN LYMPHOMA PATIENTS AFTER COMPLETION OF CHEMOTHERAPY: A PROSPECTIVE STUDYuk-UA
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record